Report cover image

Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

Publisher Renub Research
Published Mar 01, 2023
Length 190 Pages
SKU # RNBR17831882

Description

Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

Switzerland Diabetes Market will reach US$ 1.99 Billion at a CAGR of 4.71% by 2028, according to Renub Research. Almost half a million people in Switzerland have diabetes, which is constantly rising. Diabetes is an essential public health paging, one of four priority non-infectious diseases targeted for action by world leaders. The prevalence of Swiss Diabetes has been steadily increasing over the past few decades. Due to population boost, urbanization, aging, and the rising prevalence of obesity, the number of individuals with Diabetes is growing. Improving glycemic control is associated with reducing late complications of Diabetes, such as cardiovascular and micro vascular diseases. Therefore, treatment guidelines were established internationally by prominent and renowned associations and adopted by many countries.

Type 2 Diabetes is Increasing Year on Year

In Switzerland, Diabetes affects approximately 5% of the population; type 2 diabetes, the most common type, affects about 500,000 people, while type 1 diabetes affects about 40,000 people, according to the Swiss Medical Net. Diabetes can lead to complications in many body parts and increase the risk of dying prematurely. Possible complications include kidney failure, leg amputation, heart attack, stroke, nerve damage, and vision loss.

In addition, patients with T2D must have a BMI of ≥ 28 kg/m2 for health insurance to reimburse semaglutide treatment. This may have had implications for the patients enrolled in SURE Switzerland. According to our research study Diabetes Market in Switzerland was valued at US$ 1.51 Billion in 2022.

Increasing Number of Diabetes in Switzerland will create more demand for Insulin Pen Market

Based on devices, Switzerland Diabetes Market is classified into four types: Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), and Insulin Pump and Insulin Pens. Insulin pens will hold the maximum share during the upcoming years due to the rising prevalence of Diabetes in various age groups; increasing R&D activities also boost the insulin pen market. Currently, over 95% of the insulin used in Switzerland is sold in a concentration of 40 units per ml. However, only recently, a small but increasing amount of more concentrated insulin has been introduced through ""pen"" injectors designed for U-100 (= 100 units per ml) insulin.

With the greater ease of use of insulin pens, people in Switzerland with visual impairment or reduced dexterity may significantly benefit from using an insulin pen rather than a vial and syringe. However, once in use, most insulin analog vials, cartridges, and prefilled pens must be discarded after 28 days. Moreover, SMBG, Insulin Pumps, and CMG will also grow in Switzerland during the upcoming year. The Insulin Pump is especially suitable for patients with type-1 Diabetes who require a continuous supply of insulin and need to balance every meal with additional insulin.

Switzerland Health Policy

The Swiss healthcare system's duties and responsibilities are divided among cantonal, federal and municipal governments. Each of the 26 cantons was responsible for licensing providers, coordinating hospital services, promoting health through disease prevention, and subsidizing institutions and individual premiums. The federal government regulates system financing, ensures the safety and quality of pharmaceuticals and medical devices, oversees public health initiatives, and promotes research and training. The municipalities organize and provide long-term care (nursing home care and home care services) and other social support services for vulnerable groups.

Key Company

The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Sanofi, Eli Lilly and Company, Becton Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Biocon, Medtronic, Insulet Corporation, Abbott Laboratories, Terumo Corporation, and Dexcom Inc.

In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.

Renub Research report titled “Switzerland Diabetes Market & Forecast, By Continuous Glucose Monitoring Analysis (Glucose Sensor Market &Forecast, CGM Transmitter Market& Forecast, CGM User, and CGM Reimbursement), Self-Monitoring Blood GlucoseAnalysis(Test Strips Market& Forecast, Lancet Market & Forecast, Meter Market and Forecast, Blood Glucose (SMBG) Users and Blood Glucose Devices Reimbursement), Insulin Pen Analysis (Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, insulin Pen Needle Market, insulin Pen Users, and reimbursement Policies), Insulin Pump Analysis (Insulin Pump Market, Insulin Pump Users, Insulin Pump Products and Reimbursement), Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Switzerland Diabetes Market.

Switzerland Segments Market based on Devices

Segments Market based on Devices

1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump

Switzerland Diabetes Sub-Segment Analysis

1. Continuous Glucose Monitoring (CGM)

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement

2. SMBG

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement

3. Insulin Pen Market

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies

4. Insulin Pump Market

1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies

All the 13 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. Insulet Cororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care

Table of Contents

190 Pages
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Switzerland Diabetes Market
6. Switzerland Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Switzerland Diabetes Market Share Analysis
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) – Market & Users
8.1 Switzerland - CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Switzerland
9. Blood Glucose Device (SMBG) – Switzerland Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Switzerland
10. Insulin Pen – Switzerland Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen Needle Market
10.3 Insulin Pen User
10.3.1 Disposable Insulin Pen User
10.3.2 Reusable Insulin Pen User
10.3.3 Smart Insulin Pen User
10.4 Reimbursement Policies of Insulin Pen in Switzerland
11. Insulin Pump - Switzerland Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Switzerland
12. Insulin Pen – Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue
13. Insulin Pump – Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
14. SMBG – Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue
15. CGM – Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue
List of Figures:
Figure-01: Switzerland – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: Switzerland – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: Switzerland – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: Switzerland – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: Switzerland – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: Switzerland – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: Switzerland – Glucose Sensor Market (Million US$), 2017 – 2023
Figure-08: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
Figure-09: Switzerland – CGM Transmitter Market (Million US$), 2017 – 2023
Figure-10: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
Figure-11: Switzerland – CGM User (Number), 2017 – 2023
Figure-12: Switzerland – Forecast for CGM User (Number), 2023 – 2028
Figure-13: Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: Switzerland – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: Switzerland – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: Switzerland – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: Switzerland – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: Switzerland – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: Switzerland – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: Switzerland – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: Switzerland – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: Switzerland – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: Switzerland – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: Switzerland – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: Switzerland – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: Switzerland – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: Switzerland – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: Switzerland – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: Switzerland – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: Switzerland – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: Switzerland – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: Switzerland – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: Switzerland – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-45: Switzerland – Insulin Pen Needle Market (Million US$), 2017 – 2023
Figure-46: Switzerland – Forecast for Pen Needle Market (Million US$), 2023 – 2028
Figure-39: Switzerland – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: Switzerland – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: Switzerland – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: Switzerland – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: Switzerland – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: Switzerland – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-47: Switzerland – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: Switzerland – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: Switzerland – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: Switzerland – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: Switzerland – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: Switzerland – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: Switzerland – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: Switzerland – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Million US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028
List of Tables:
Table-01: Switzerland – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Switzerland – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us